My goal is to develop substantial Australian capacity and international leadership in research on Health Impacts of Environment and Climate Change. Climate change poses diverse health risks, both direct (heatwaves, weather disasters, drought, urban air quality) and indirect (infectious disease patterns, food yields, economic loss, environmental refugee flows). My research group, with my own international connections and our strong cross-campus and external collaborative links, is ideally placed ....My goal is to develop substantial Australian capacity and international leadership in research on Health Impacts of Environment and Climate Change. Climate change poses diverse health risks, both direct (heatwaves, weather disasters, drought, urban air quality) and indirect (infectious disease patterns, food yields, economic loss, environmental refugee flows). My research group, with my own international connections and our strong cross-campus and external collaborative links, is ideally placed to do this research. Major outcomes will be: (i) enhanced understanding of the health risks from climate change and other human-induced environmental changes (including studies of their influences on patterns of infectious diseases); (ii) a broader evidence base for developing preventive-adaptive strategies to lessen health risks – and further development of my Centre’s high-level skills in translating research to social policy. My four specific aims are to: 1. Extend our research on the health impacts of climate change and other environmental changes. This will include strengthening further our international collaboration, developing new methods, and: (a) research on the health impacts of long-term drought in rural Australia; (b) elucidating the interplay of environmental, climatic, social and economic influences on infectious disease emergence and spread in the Australia-Asia region (to enhance ecological understanding, facilitate prevention-control strategies, and advance the biosecurity research agenda – including via ANU’s new Centre for Biosecurity). 2. Develop further our research on environmental and genetic influences on immune system function and autoimmune diseases, including studying the role of vitamin D. Answers to these research questions will be generalisable to the prevention and management of immune disorders. 3. Provide strong leadership in fostering international research activities, capacity and collaboration on the health impacts of global environmental-climatic changes (GEC). I have special opportunity and responsibility as co-chair of the International Council of Science project: ‘GEC and Human Health’. 4. Develop Australia’s population health research capacity with emphasis on training early-mid-career researchers. This fellowship research program would be greatly strengthened by retention of several high-performing and committed Team Investigators already working in the topic area. My central objective is to consolidate national research capacity and long-term momentum in the above areas, with high international engagement and profile. Under my directorship NCEPH has attained high visibility in: (i) climate change and health research; (ii) modeling infectious disease transmission and control; (iii) studying the environmental aetiology of immune disorders; and (iv) social-cultural epidemiological research into influences on health-reRead moreRead less
Melanoma is one of Australia?s major cancer problems, but we still do not completely understand why certain people are at higher risk than others. This study is focussed on people who have developed melanoma at an early age (under 40yrs) and will compare their family history of cancer, skin features, genetic characteristics and various aspects of their previous sun exposure with people who don?t have melanoma. The large number of people involved and the fact that they will be selected at random ....Melanoma is one of Australia?s major cancer problems, but we still do not completely understand why certain people are at higher risk than others. This study is focussed on people who have developed melanoma at an early age (under 40yrs) and will compare their family history of cancer, skin features, genetic characteristics and various aspects of their previous sun exposure with people who don?t have melanoma. The large number of people involved and the fact that they will be selected at random from the population of Melbourne, Sydney and Brisbane which have very different melanoma rates, means that the study will be able to clarify what roles genes and environment play in the disease. It is intended to be an international benchmark in this regard, and Australia is the only country in which a study of this scope could be mounted. Potential benefits from this research will be a better understanding of the way sun exposure affects people differently, depending on their genetic makeup, the place of genetic testing in assessing people?s risk of melanoma, particularly if they have relatives with the disease, and way in which skin features like moles should be taken into account in that assessment. Finally, it is likely that better information about the types of genetic susceptibility to melanoma in the population will translate to more effective programs for the prevention of melanoma and for detection of melanomas efficiently at the earliest possible stage.Read moreRead less
Investigating Low Sun Exposure And Other Possible Early Life Determinants Of Type 1 Diabtes Mellitus
Funder
National Health and Medical Research Council
Funding Amount
$342,795.00
Summary
Type 1 diabetes mellitus is becoming more common among Australian children. The project explores aspects of the modern child's environment that may increase the risk of type 1 diabetes. In particular it aims to assess whether very low sun exposure in early life is adverse. Low sun exposure may be adverse because sun exposure -derived vitamin D is vital for the developing child's immune system. We need to know what level of sunlight and vitamin D children need to prevent disease.
The Role Of Past Sun Exposure, Infection History And Other Exogenous Factors In Multiple Sclerosis
Funder
National Health and Medical Research Council
Funding Amount
$92,011.00
Summary
Multiple Sclerosis (MS) is a chronic autoimmune inflammatory disease of the brain and spinal cord that leads to various degrees of disability. The causes of MS are not yet known, and there is presently no cure. However, there is strong evidence that both an inherited susceptibility and environmental factors are important. This environmental case control study will be conducted in Tasmania and will run concurrent to a genetic project on MS which allows assessment of gene-environment interactions. ....Multiple Sclerosis (MS) is a chronic autoimmune inflammatory disease of the brain and spinal cord that leads to various degrees of disability. The causes of MS are not yet known, and there is presently no cure. However, there is strong evidence that both an inherited susceptibility and environmental factors are important. This environmental case control study will be conducted in Tasmania and will run concurrent to a genetic project on MS which allows assessment of gene-environment interactions. It focuses on infections, timing of childhood infections and long term sun exposure. It has been suggested that MS may be due to an immune disturbance following viral infection and that the timing of childhood infections may be initially important. Also, in Australia, there is a sevenfold increase in MS prevalence as one moves from Queensland to Tasmania. This latitudinal gradient might be due to ultra violet radiation, through an influence on immune function. Beside those main focuses, the study will include other environmental factors like chemicals, diet and vaccinations. Hopefully this project will contribute to a better understanding of the causes of MS, which are relevant for preventative strategies and devising optimal treatment.Read moreRead less
Estimating The Burden Of Group A Streptococcal Diseases In Victoria
Funder
National Health and Medical Research Council
Funding Amount
$386,760.00
Summary
Despite the considerable advances in the diagnosis and treatment of group A streptococcal (GAS) diseases made during the last century, the impressive spectrum of infections caused by this organism continues to have a significant impact in developed countries. This spectrum includes diseases that are mild but common (e.g. sore throat, skin sores), rare but very severe (e.g. bloodstream infections, flesh-eating bacteria) and those that are more common in developing countries and the Aboriginal pop ....Despite the considerable advances in the diagnosis and treatment of group A streptococcal (GAS) diseases made during the last century, the impressive spectrum of infections caused by this organism continues to have a significant impact in developed countries. This spectrum includes diseases that are mild but common (e.g. sore throat, skin sores), rare but very severe (e.g. bloodstream infections, flesh-eating bacteria) and those that are more common in developing countries and the Aboriginal population (e.g. rheumatic fever, kidney disease). Streptococcal sore throat remains one of the most common childhood infections, and severe group A streptococcal diseases are thought to be increasing in incidence in Australia. Yet, there are no accurate data on the incidence and costs of these or other GAS diseases in non-Aboriginal Australians, or in most other populations around the world. It is becoming more urgent to collect this data as numerous vaccine candidates are entering human trials, new approaches to the treatment of sore throat are emerging, and new strategies to treat and control the spread of severe disease are being developed. We propose a comprehensive strategy to measure the incidence, prevalence and costs of each group of GAS diseases. We will follow a group of families for 12 months to detect cases of GAS sore throat and skin sores and measure the impact on the family. We will survey children in schools to estimate the prevalence of skin sores. We will check hospital records to calculate the number of cases of rheumatic fever and kidney disease. And we will maintain surveillance for severe diseases by checking hospital and laboratory records. We will also check to see if family members of people with severe disease have the GAS bacterium in their throats. We will then compile these data into a comprehensive estimate of the burden of disease in Victoria, and estimate the cost-effectiveness of different treatment and prevention strategies.Read moreRead less
LONG TERM FUNCTIONAL ABILITY AND COSTS OF STROKE SUBTYPES.
Funder
National Health and Medical Research Council
Funding Amount
$270,604.00
Summary
Stroke is the third most common cause of death in Australia, and is more common in the older age groups. Because the population most at risk of developing stroke is growing faster than the rest of the population, it is likely that there will be a large increase in the number of strokes occurring in coming years. At 1 year after stroke about one-third of patients have died, a third remain severely disabled and a third recover with minimal disability. In Australia, there is little information on o ....Stroke is the third most common cause of death in Australia, and is more common in the older age groups. Because the population most at risk of developing stroke is growing faster than the rest of the population, it is likely that there will be a large increase in the number of strokes occurring in coming years. At 1 year after stroke about one-third of patients have died, a third remain severely disabled and a third recover with minimal disability. In Australia, there is little information on outcome beyond 1 year. It is thought that at 5 years after stroke about 55% of patients will die, and a further 10% will have another nonfatal stroke. Stroke is estimated to cost the community in excess of $1 billion a year. Little is known about the long-term costs of stroke to survivors and their relatives. These costs are likely to be substantial, and are likely to include costs related to hospitalisations, outpatient visits, general practitioner visits, medications, aids and community services. It is also likely that substantial informal care is provided by relatives and friends (e.g. assistance with shopping and personal care). The aim of this study is to assess the long-term outcome of patients with stroke. These will include measures of survival, stroke recurrence, and ability to perform usual daily activities. In addition, we aim to determine the long-term use of health care and community resources and the costs incurred by patients, their carers, and the community. Information on survival patterns, stroke recurrence and disability will provide information of great value for health service planning. Such information will also be useful to patients, their families, and medical staff who treat these patients. Information on the costs of stroke will provide the only information about the patterns of long-term health care and community resource use among stroke patients in Australia. This information will be useful for health service planning.Read moreRead less